Skip Nav Destination
Issues
Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition
Jingwei Zhang; Adam J. Pearson; Nitin Sabherwal; Brian A. Telfer; Nisha Ali; Karmern Kan; Qiuping Xu; Wei Zhang; Fuhui Chen; Shiyang Li; Jinhua Wang; Nathanael S. Gray; Blanca Risa-Ebrí; Katherine G. Finegan; Michael J. Cross; Emanuele Giurisato; Alan J. Whitmarsh; Cathy Tournier
Conduit CAR: Redirecting CAR T-Cell Specificity with A Universal and Adaptable Bispecific Antibody Platform
M. Jack Borrok; Yonghai Li; Paul B. Harvilla; Bharathikumar Vellalore Maruthachalam; Ninkka Tamot; Christine Prokopowitz; Jun Chen; Sathya Venkataramani; Iqbal S. Grewal; Rajkumar Ganesan; Sanjaya Singh
Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors
Ana M. Metelo; Agnieszka Jozwik; Le Anh Luong; Delaney Dominey-Foy; Charlotte Graham; Charlotte Attwood; Shafqat Inam; Alan Dunlop; Katy Sanchez; Kirsty Cuthill; Carmel Rice; Matthew Streetly; Trevor Bentley; Bijan Boldajipour; Cesar Sommer; Barbra Sasu; Reuben Benjamin
MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner
Alina Castell; Qinzi Yan; Karin Fawkner; Wesam Bazzar; Fan Zhang; Malin Wickström; Mohammad Alzrigat; Marcela Franco; Cecilia Krona; Donald P. Cameron; Cecilia Dyberg; Thale Kristin Olsen; Vasiliki Verschut; Linnéa Schmidt; Sheryl Y. Lim; Loay Mahmoud; Per Hydbring; Sören Lehmann; Laura Baranello; Sven Nelander; John Inge Johnsen; Lars-Gunnar Larsson
Advertisement